Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.86), versus ($0.91) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.